BioMarin will discontinue dosing and enrollment of its phase 2 trials for Voxzogo—currently approved in achondroplasia, a ...

BioMarin will stop dosing in Phase II trials of the drug in Turner Syndrome, SHOX-deficiency and Aggrecan deficiency.

Achondroplasia, also known as short-limb dwarfism, is associated with neurological symptoms and complications due to narrowing of the skeletal structures surrounding the spinal cord. Despite ...

CEO Todd Harris said the company has narrowed its focus to what he described as the “highest value opportunities” for its ...

A year of daily subcutaneous vosoritide was associated with a 0.6-inch (1.5-cm) greater increase in height than placebo in children with achondroplasia, the most common form of human dwarfism. There ...

The oral FGFR1-3 selective tyrosine kinase inhibitor infigratinib was found to be safe and effective at the highest studied dose among children with achondroplasia in a phase II dose-finding study.

"People like me are endangered and now they want to make me extinct," Little People of America spokeswoman Leah Smith said in 2015 of the growth drug vosoritide. Getty Images for MAKERS A new drug ...

March 16 (Reuters) - BioMarin Pharmaceutical will discontinue mid-stage trials of its bone disorder treatment after reports ...

A Prescription Drug User Fee Act target date of November 30, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application ...

A groundbreaking drug that helps regulate bone development has boosted growth rates in children with achondroplasia - the most common type of dwarfism - in a global trial led by Melbourne's Murdoch ...

Q: Which doctor can I consult if my baby is diagnosed with achondroplasia? A: You will have to consult a pediatrician, orthopedic surgeon, dental surgeon and a neurosurgeon depending on the ...

The Food and Drug Administration approved the first treatment for the most common cause of dwarfism Friday, a drug that has proved to increase children’s height but has been polarizing among adults ...